在COVID-19和败血症的辅助治疗-我们学到了什么?
Evangelos J Giamarellos-Bourboulis1
1Fourth Department of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, Medical School, 1 Rimini Street, 124 62 Athens, Greece. egiamarel@med.uoa.gr.
Medizinische Klinik, Intensivmedizin und Notfallmedizin
|November 15, 2023
概括
针对2019年严重冠状病毒病 (COVID-19) 的免疫疗法为细菌性败血症治疗提供了见解. 选择合适的败血症免疫疗法药物需要生物标志物来指导基于特定机制的治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的COVID-19治疗方法,如阿纳金拉,巴里西提尼布和托西利祖马布,突出显示了免疫治疗的作用.
- 这种方法可以推断为细菌性败血症治疗策略.
研究的目的:
- 审查COVID-19的免疫疗法及其对败血症的潜在应用.
- 确定有效的败血症免疫治疗的关键原则.
主要方法:
- 使用了三步方法,分析了COVID-19免疫疗法的临床证据.
- 研究人员审查了人类和动物在败血症中对细胞的研究.
- 从COVID-19免疫疗法中吸取的经验教训应用于败血症治疗.
主要成果:
- COVID-19免疫疗法在病毒清除方面取得了成功.
- 有证据支持对败血症的细胞增强策略.
- 以生物标志物为指导的药物选择对于败血症免疫治疗至关重要.
结论:
- 败血症免疫疗法应根据生物标志物量身定制.
- 生物标志物表明特定的主导机制,使适当的药物选择.
- 这种个性化的方法优化了败血症治疗结果.
相关概念视频
01:28Pneumonia IV: Management
338
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
338
01:22Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
15
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
15
01:30Pneumonia III: Complications and Assessment
241
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
241
01:26Tonsillitis II: Management
120
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
120
01:18Endocarditis III: Medical Management
8
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
8